Eli Lilly Pulling Sepsis Drug Xigris


Following the results of a recent study which showed that Eli Lilly’s sepsis drug, Xigris, provided no better results in reducing mortality than that of a placebo, the pharmaceutical company announced it will pull the product from the market worldwide. Both The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have [...]